Cargando…

Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition

Hypertrophic scarring (HS), caused by excessive fibrosis of injured skin, imposes a psychological burden and creates a source of distress that impairs the quality of life of affected individuals. However, the gold standard for HS treatment has not yet been determined due to the complicated and diffi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaoyi, Yin, Libo, Li, Yuanyuan, Cao, Yi, Zeng, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200508/
https://www.ncbi.nlm.nih.gov/pubmed/35722137
http://dx.doi.org/10.1155/2022/7331164
_version_ 1784728075503665152
author Li, Zhaoyi
Yin, Libo
Li, Yuanyuan
Cao, Yi
Zeng, Haifeng
author_facet Li, Zhaoyi
Yin, Libo
Li, Yuanyuan
Cao, Yi
Zeng, Haifeng
author_sort Li, Zhaoyi
collection PubMed
description Hypertrophic scarring (HS), caused by excessive fibrosis of injured skin, imposes a psychological burden and creates a source of distress that impairs the quality of life of affected individuals. However, the gold standard for HS treatment has not yet been determined due to the complicated and difficult nature of the routines and procedures involved. Previous studies have indicated that the topical application of certain active components found in traditional Chinese medicines shows potential as a therapeutic alternative for scars. Here, single-cell RNA-sequencing was performed to determine cellular heterogeneity and identify marker genes and mechanisms associated with HS. It was found that fibroblasts comprise the largest proportion of HS cell types. The marker genes that were highly expressed in fibroblasts were extracellular matrix (ECM)-related, whereas ECM-receptor interactions and the transforming growth factor (TGF)-β signalling pathway were also found to be active. Ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry, which was applied to identify the molecular compounds of Dispel-Scar Ointment (DSO), revealed 74 effective chemical components belonging to 14 types of constituents, such as flavonoids, tanshinones, salvianolic acids, glycosides, and phthalides. Furthermore, in vivo studies using rat scar models showed that the topical application of Salvia miltiorrhiza, Ligusticum chuanxiong, peach kernel, safflower, and motherwort exerted beneficial effects on fibroblasts. DSO promoted scar maturation and reduced scar areas, its efficacy being similar to that of topically applied silicone. Functional studies using immunofluorescence staining, western blotting, and quantitative real-time polymerase chain reaction demonstrated that DSO may target the TGF-β/Smad pathway to inhibit collagen synthesis and promote ECM remodelling. However, further in vitro mechanistic research and single-drug prescription studies may be required to identify the specific effective compound or active ingredient of DSO, which would provide more substantial evidence regarding the potential therapeutic value of traditional herbs in HS.
format Online
Article
Text
id pubmed-9200508
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92005082022-06-16 Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition Li, Zhaoyi Yin, Libo Li, Yuanyuan Cao, Yi Zeng, Haifeng Evid Based Complement Alternat Med Research Article Hypertrophic scarring (HS), caused by excessive fibrosis of injured skin, imposes a psychological burden and creates a source of distress that impairs the quality of life of affected individuals. However, the gold standard for HS treatment has not yet been determined due to the complicated and difficult nature of the routines and procedures involved. Previous studies have indicated that the topical application of certain active components found in traditional Chinese medicines shows potential as a therapeutic alternative for scars. Here, single-cell RNA-sequencing was performed to determine cellular heterogeneity and identify marker genes and mechanisms associated with HS. It was found that fibroblasts comprise the largest proportion of HS cell types. The marker genes that were highly expressed in fibroblasts were extracellular matrix (ECM)-related, whereas ECM-receptor interactions and the transforming growth factor (TGF)-β signalling pathway were also found to be active. Ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry, which was applied to identify the molecular compounds of Dispel-Scar Ointment (DSO), revealed 74 effective chemical components belonging to 14 types of constituents, such as flavonoids, tanshinones, salvianolic acids, glycosides, and phthalides. Furthermore, in vivo studies using rat scar models showed that the topical application of Salvia miltiorrhiza, Ligusticum chuanxiong, peach kernel, safflower, and motherwort exerted beneficial effects on fibroblasts. DSO promoted scar maturation and reduced scar areas, its efficacy being similar to that of topically applied silicone. Functional studies using immunofluorescence staining, western blotting, and quantitative real-time polymerase chain reaction demonstrated that DSO may target the TGF-β/Smad pathway to inhibit collagen synthesis and promote ECM remodelling. However, further in vitro mechanistic research and single-drug prescription studies may be required to identify the specific effective compound or active ingredient of DSO, which would provide more substantial evidence regarding the potential therapeutic value of traditional herbs in HS. Hindawi 2022-06-08 /pmc/articles/PMC9200508/ /pubmed/35722137 http://dx.doi.org/10.1155/2022/7331164 Text en Copyright © 2022 Zhaoyi Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Zhaoyi
Yin, Libo
Li, Yuanyuan
Cao, Yi
Zeng, Haifeng
Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition
title Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition
title_full Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition
title_fullStr Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition
title_full_unstemmed Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition
title_short Single-Cell RNA-Sequencing Reveals the Cellular and Genetic Heterogeneity of Skin Scar to Verify the Therapeutic Effects and Mechanism of Action of Dispel-Scar Ointment in Hypertrophic Scar Inhibition
title_sort single-cell rna-sequencing reveals the cellular and genetic heterogeneity of skin scar to verify the therapeutic effects and mechanism of action of dispel-scar ointment in hypertrophic scar inhibition
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200508/
https://www.ncbi.nlm.nih.gov/pubmed/35722137
http://dx.doi.org/10.1155/2022/7331164
work_keys_str_mv AT lizhaoyi singlecellrnasequencingrevealsthecellularandgeneticheterogeneityofskinscartoverifythetherapeuticeffectsandmechanismofactionofdispelscarointmentinhypertrophicscarinhibition
AT yinlibo singlecellrnasequencingrevealsthecellularandgeneticheterogeneityofskinscartoverifythetherapeuticeffectsandmechanismofactionofdispelscarointmentinhypertrophicscarinhibition
AT liyuanyuan singlecellrnasequencingrevealsthecellularandgeneticheterogeneityofskinscartoverifythetherapeuticeffectsandmechanismofactionofdispelscarointmentinhypertrophicscarinhibition
AT caoyi singlecellrnasequencingrevealsthecellularandgeneticheterogeneityofskinscartoverifythetherapeuticeffectsandmechanismofactionofdispelscarointmentinhypertrophicscarinhibition
AT zenghaifeng singlecellrnasequencingrevealsthecellularandgeneticheterogeneityofskinscartoverifythetherapeuticeffectsandmechanismofactionofdispelscarointmentinhypertrophicscarinhibition